ClinicalTrials.Veeva

Menu

Reducing Stress in Adolescents and Young Adults With Type 1 Diabetes to Improve Diabetes Care (T1D)

Wayne State University logo

Wayne State University

Status

Completed

Conditions

Type 1 Diabetes

Treatments

Behavioral: Cognitive Behavioral Therapy
Behavioral: Diabetes Support and Education
Behavioral: Mindfulness Based Stress Reduction

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT02760303
R01DK059067 (U.S. NIH Grant/Contract)
066115B3E

Details and patient eligibility

About

Adolescence and young adulthood may be particularly stressful developmental periods due to the numerous transitions into new roles and the need for increased independence. Stress can affect metabolic control in older adolescents and young adults with T1D directly through its impact on cortisol and other hormones that affect insulin metabolism.

The proposed study is a pilot randomized clinical trial using a three-group randomized, repeated measures design to assess the efficacy of two treatments (Mindfulness Based Stress Reduction (MBSR) and Cognitive Behavioral Therapy or (CBT) versus an attention control condition for older adolescents and young adults with poorly controlled Type 1 diabetes. As a pilot study, the goal of the research is to test recruitment and retention procedures, finalize intervention measures, training, and fidelity protocols, and estimate effect sizes for a larger clinical trial.

Full description

This study will use a randomized, repeated measures design. A sample of 125 participants will be recruited and consented from the Children's Hospital of Michigan and outpatient diabetes clinics affiliated with the Detroit Medical Center. 108 will be randomized to one of three treatment conditions (remaining participants are expected to consent but not enroll or fail to initiate treatment). These participants will be enrolled in 3 cohorts of 30-36 participants.

Measures will be administered at 3 home-based study visits to maximize participant convenience. The initial study visit (Visit 1) will be scheduled at the beginning of the study. Visit 2 will coincide with the end of treatment which is approximately 3 months after the initial study visit. Visit 3 is the 3-month follow up and will be scheduled about 6 months after the initial study visit. At each visit, participants will complete questionnaires assessing their current diabetes management, stressors, quality of life, mental health, and demographic characteristics. These questionnaires will be completed using Qualtrics accessed via the internet on a university laptop computer. A research assistant will download the participant's glucose meter to obtain the frequency of blood glucose testing during the two weeks preceding data collection. The research assistant will also assist participants with providing a blood sample via fingerstick (HbA1c) and saliva samples by mouth (cortisol, Visits 1 and 2 only). All participants will be asked to take part in an exit interview at Visit 3 to obtain feedback on the treatment they received.

After Visit 1, participants will be randomized using a 1:1:1 ratio to MBSR, CBT, or Diabetes Support and Education (DSE). All three treatments are group format meeting (10-12 participants per group) for nine consecutive weeks at a location convenient to the participants. In MBSR treatment focuses on the instruction and practice of mindfulness techniques, such as meditation and yoga, and the application of these practices to everyday activities. CBT utilizes activities to understand how thoughts affect emotions and behaviors, the application of these activities to current stressors, and strategies to apply these new skills to future stressors. The DSE group is the attention control condition; DSE participants will receive diabetes education via a support group format. All group sessions will be audiotaped for treatment fidelity monitoring and assessment. There are no planned research interventions for the DSE group.

Enrollment

60 patients

Sex

All

Ages

16 to 20 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Aged 16 years, 0 months to 20 years, 11 months
  2. Diagnosed with type 1 diabetes for at least six months
  3. Poor metabolic control as defined by HbA1c >=9%

Exclusion criteria

  1. Mental health conditions that might compromise data integrity (e.g., developmental delay, psychosis, suicidality)
  2. Co-morbid medical condition resulting in atypical diabetes management (e.g., cystic fibrosis)
  3. Inability to speak or read English

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

60 participants in 3 patient groups

Cognitive Behavioral Therapy
Experimental group
Description:
Hains' adaptation of cognitive behavioral therapy for adolescents and young adults with type 1 diabetes
Treatment:
Behavioral: Cognitive Behavioral Therapy
Mindfulness Based Stress Reduction
Experimental group
Description:
Sabinga's adaptation of Mindfulness Based Stress Reduction for adolescents and young adults with type 1 diabetes
Treatment:
Behavioral: Mindfulness Based Stress Reduction
Diabetes Support and Education
Active Comparator group
Description:
Investigator developed peer support group and diabetes education
Treatment:
Behavioral: Diabetes Support and Education

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems